Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - GeoVax Labs, Inc.ex_107988.htm
EX-31.2 - EXHIBIT 31.2 - GeoVax Labs, Inc.ex_107987.htm
EX-31.1 - EXHIBIT 31.1 - GeoVax Labs, Inc.ex_107986.htm
EX-10.18 - EXHIBIT 10.18 - GeoVax Labs, Inc.ex_107985.htm
EX-10.17 - EXHIBIT 10.17 - GeoVax Labs, Inc.ex_108048.htm
EX-10.16 - EXHIBIT 10.16 - GeoVax Labs, Inc.ex_108047.htm
EX-10.72 - EXHIBIT 10.7.2 - GeoVax Labs, Inc.ex_108049.htm
EX-10.42 - EXHIBIT 10.4.2 - GeoVax Labs, Inc.ex_107983.htm
EX-10.33 - EXHIBIT 10.3.3 - GeoVax Labs, Inc.ex_107982.htm
EX-10.32 - EXHIBIT 10.3.2 - GeoVax Labs, Inc.ex_107981.htm
EX-10.23 - EXHIBIT 10.2.3 - GeoVax Labs, Inc.ex_107980.htm
EX-10.22 - EXHIBIT 10.2.2 - GeoVax Labs, Inc.ex_107979.htm
EX-10.13 - EXHIBIT 10.1.3 - GeoVax Labs, Inc.ex_107978.htm
EX-10.12 - EXHIBIT 10.1.2 - GeoVax Labs, Inc.ex_107977.htm
10-K - FORM 10-K - GeoVax Labs, Inc.govx20171231_10k.htm

Exhibit 32.2

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of GeoVax Labs, Inc. (the "Company") on Form 10-K for the year ended December 31, 2017, I, Mark W. Reynolds, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:

 

1.

The annual report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2.

The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company

 

 

 

 Dated: March 23, 2018

 

/s/ Mark W. Reynolds

 
    Mark W. Reynolds  
    Chief Financial Officer